Global Human Antithrombin III Market Insights, Forecast to 2028

TABLE OF CONTENTS

1 Study Coverage

• 1.1 Human Antithrombin III Product Introduction
• 1.2 Market by Form
  • 1.2.1 Global Human Antithrombin III Market Size Growth Rate by Form, 2017 VS 2021 VS 2028
  • 1.2.2 Lyophilized Form
  • 1.2.3 Liquid Form
• 1.3 Market by Application
  • 1.3.1 Global Human Antithrombin III Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
  • 1.3.2 Hmophilia
  • 1.3.3 Aplastic Anemia
  • 1.3.4 Heart Valve Disease
  • 1.3.5 Other
• 1.4 Study Objectives
• 1.5 Years Considered

2 Executive Summary

• 2.1 Global Human Antithrombin III Sales Estimates and Forecasts 2017-2028
• 2.2 Global Human Antithrombin III Revenue Estimates and Forecasts 2017-2028
• 2.3 Global Human Antithrombin III Revenue by Region: 2017 VS 2021 VS 2028
• 2.4 Global Human Antithrombin III Sales by Region
  • 2.4.1 Global Human Antithrombin III Sales by Region (2017-2022)
  • 2.4.2 Global Sales Human Antithrombin III by Region (2023-2028)
• 2.5 Global Human Antithrombin III Revenue by Region
  • 2.5.1 Global Human Antithrombin III Revenue by Region (2017-2022)
  • 2.5.2 Global Human Antithrombin III Revenue by Region (2023-2028)
• 2.6 North America
• 2.7 Europe
• 2.8 Asia-Pacific
• 2.9 Latin America
• 2.10 Middle East & Africa

3 Competition by Manufacturers

• 3.1 Global Human Antithrombin III Sales by Manufacturers
  • 3.1.1 Global Top Human Antithrombin III Manufacturers by Sales (2017-2022)
  • 3.1.2 Global Human Antithrombin III Sales Market Share by Manufacturers (2017-2022)
  • 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Human Antithrombin III in 2021
• 3.2 Global Human Antithrombin III Revenue by Manufacturers
  • 3.2.1 Global Human Antithrombin III Revenue by Manufacturers (2017-2022)
  • 3.2.2 Global Human Antithrombin III Revenue Market Share by Manufacturers (2017-2022)
  • 3.2.3 Global Top 10 and Top 5 Companies by Human Antithrombin III Revenue in 2021
• 3.3 Global Human Antithrombin III Sales Price by Manufacturers (2017-2022)
• 3.4 Analysis of Competitive Landscape
  • 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Human Antithrombin III Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 3.4.3 Global Human Antithrombin III Manufacturers Geographical Distribution
• 3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Form

• 4.1 Global Human Antithrombin III Sales by Form
  • 4.1.1 Global Human Antithrombin III Historical Sales by Form (2017-2022)
  • 4.1.2 Global Human Antithrombin III Forecasted Sales by Form (2023-2028)
  • 4.1.3 Global Human Antithrombin III Sales Market Share by Form (2017-2028)
• 4.2 Global Human Antithrombin III Revenue by Form
  • 4.2.1 Global Human Antithrombin III Historical Revenue by Form (2017-2022)
  • 4.2.2 Global Human Antithrombin III Forecasted Revenue by Form (2023-2028)
  • 4.2.3 Global Human Antithrombin III Revenue Market Share by Form (2017-2028)
• 4.3 Global Human Antithrombin III Price by Form
  • 4.3.1 Global Human Antithrombin III Price by Form (2017-2022)
  • 4.3.2 Global Human Antithrombin III Price Forecast by Form (2023-2028)

5 Market Size by Application

• 5.1 Global Human Antithrombin III Sales by Application
  • 5.1.1 Global Human Antithrombin III Historical Sales by Application (2017-2022)
  • 5.1.2 Global Human Antithrombin III Forecasted Sales by Application (2023-2028)
  • 5.1.3 Global Human Antithrombin III Sales Market Share by Application (2017-2028)
• 5.2 Global Human Antithrombin III Revenue by Application
  • 5.2.1 Global Human Antithrombin III Historical Revenue by Application (2017-2022)
  • 5.2.2 Global Human Antithrombin III Forecasted Revenue by Application (2023-2028)
  • 5.2.3 Global Human Antithrombin III Revenue Market Share by Application (2017-2028)
• 5.3 Global Human Antithrombin III Price by Application
  • 5.3.1 Global Human Antithrombin III Price by Application (2017-2022)
  • 5.3.2 Global Human Antithrombin III Price Forecast by Application (2023-2028)

6 North America

• 6.1 North America Human Antithrombin III Market Size by Form
  • 6.1.1 North America Human Antithrombin III Sales by Form (2017-2028)
  • 6.1.2 North America Human Antithrombin III Revenue by Form (2017-2028)
• 6.2 North America Human Antithrombin III Market Size by Application
  • 6.2.1 North America Human Antithrombin III Sales by Application (2017-2028)
  • 6.2.2 North America Human Antithrombin III Revenue by Application (2017-2028)
• 6.3 North America Human Antithrombin III Market Size by Country
  • 6.3.1 North America Human Antithrombin III Sales by Country (2017-2028)
  • 6.3.2 North America Human Antithrombin III Revenue by Country (2017-2028)
  • 6.3.3 United States
  • 6.3.4 Canada

7 Europe

• 7.1 Europe Human Antithrombin III Market Size by Form
  • 7.1.1 Europe Human Antithrombin III Sales by Form (2017-2028)
  • 7.1.2 Europe Human Antithrombin III Revenue by Form (2017-2028)
• 7.2 Europe Human Antithrombin III Market Size by Application
  • 7.2.1 Europe Human Antithrombin III Sales by Application (2017-2028)
  • 7.2.2 Europe Human Antithrombin III Revenue by Application (2017-2028)
• 7.3 Europe Human Antithrombin III Market Size by Country
  • 7.3.1 Europe Human Antithrombin III Sales by Country (2017-2028)
  • 7.3.2 Europe Human Antithrombin III Revenue by Country (2017-2028)
  • 7.3.3 Germany
  • 7.3.4 France
  • 7.3.5 U.K.
  • 7.3.6 Italy
  • 7.3.7 Russia

8 Asia Pacific

• 8.1 Asia Pacific Human Antithrombin III Market Size by Form
  • 8.1.1 Asia Pacific Human Antithrombin III Sales by Form (2017-2028)
  • 8.1.2 Asia Pacific Human Antithrombin III Revenue by Form (2017-2028)
• 8.2 Asia Pacific Human Antithrombin III Market Size by Application
  • 8.2.1 Asia Pacific Human Antithrombin III Sales by Application (2017-2028)
  • 8.2.2 Asia Pacific Human Antithrombin III Revenue by Application (2017-2028)
• 8.3 Asia Pacific Human Antithrombin III Market Size by Region
  • 8.3.1 Asia Pacific Human Antithrombin III Sales by Region (2017-2028)
  • 8.3.2 Asia Pacific Human Antithrombin III Revenue by Region (2017-2028)
  • 8.3.3 China
  • 8.3.4 Japan
  • 8.3.5 South Korea
  • 8.3.6 India
  • 8.3.7 Australia
  • 8.3.8 China Taiwan
  • 8.3.9 Indonesia
  • 8.3.10 Thailand
  • 8.3.11 Malaysia

9 Latin America

• 9.1 Latin America Human Antithrombin III Market Size by Form
  • 9.1.1 Latin America Human Antithrombin III Sales by Form (2017-2028)
  • 9.1.2 Latin America Human Antithrombin III Revenue by Form (2017-2028)
• 9.2 Latin America Human Antithrombin III Market Size by Application
  • 9.2.1 Latin America Human Antithrombin III Sales by Application (2017-2028)
  • 9.2.2 Latin America Human Antithrombin III Revenue by Application (2017-2028)
• 9.3 Latin America Human Antithrombin III Market Size by Country
  • 9.3.1 Latin America Human Antithrombin III Sales by Country (2017-2028)
  • 9.3.2 Latin America Human Antithrombin III Revenue by Country (2017-2028)
  • 9.3.3 Mexico
  • 9.3.4 Brazil
  • 9.3.5 Argentina

10 Middle East and Africa

• 10.1 Middle East and Africa Human Antithrombin III Market Size by Form
  • 10.1.1 Middle East and Africa Human Antithrombin III Sales by Form (2017-2028)
  • 10.1.2 Middle East and Africa Human Antithrombin III Revenue by Form (2017-2028)
• 10.2 Middle East and Africa Human Antithrombin III Market Size by Application
  • 10.2.1 Middle East and Africa Human Antithrombin III Sales by Application (2017-2028)
  • 10.2.2 Middle East and Africa Human Antithrombin III Revenue by Application (2017-2028)
• 10.3 Middle East and Africa Human Antithrombin III Market Size by Country
  • 10.3.1 Middle East and Africa Human Antithrombin III Sales by Country (2017-2028)
  • 10.3.2 Middle East and Africa Human Antithrombin III Revenue by Country (2017-2028)
  • 10.3.3 Turkey
  • 10.3.4 Saudi Arabia

11 Company Profiles

• 11.1 Grifols
  • 11.1.1 Grifols Corporation Information
  • 11.1.2 Grifols Overview
  • 11.1.3 Grifols Human Antithrombin III Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.1.4 Grifols Human Antithrombin III Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.1.5 Grifols Recent Developments
• 11.2 Lee BioSolutions
  • 11.2.1 Lee BioSolutions Corporation Information
  • 11.2.2 Lee BioSolutions Overview
  • 11.2.3 Lee BioSolutions Human Antithrombin III Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.2.4 Lee BioSolutions Human Antithrombin III Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.2.5 Lee BioSolutions Recent Developments
• 11.3 ATryn
  • 11.3.1 ATryn Corporation Information
  • 11.3.2 ATryn Overview
  • 11.3.3 ATryn Human Antithrombin III Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.3.4 ATryn Human Antithrombin III Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.3.5 ATryn Recent Developments
• 11.4 LFB
  • 11.4.1 LFB Corporation Information
  • 11.4.2 LFB Overview
  • 11.4.3 LFB Human Antithrombin III Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.4.4 LFB Human Antithrombin III Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.4.5 LFB Recent Developments
• 11.5 Shire
  • 11.5.1 Shire Corporation Information
  • 11.5.2 Shire Overview
  • 11.5.3 Shire Human Antithrombin III Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.5.4 Shire Human Antithrombin III Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.5.5 Shire Recent Developments
• 11.6 CSL Limited
  • 11.6.1 CSL Limited Corporation Information
  • 11.6.2 CSL Limited Overview
  • 11.6.3 CSL Limited Human Antithrombin III Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.6.4 CSL Limited Human Antithrombin III Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.6.5 CSL Limited Recent Developments
• 11.7 Kedrion
  • 11.7.1 Kedrion Corporation Information
  • 11.7.2 Kedrion Overview
  • 11.7.3 Kedrion Human Antithrombin III Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.7.4 Kedrion Human Antithrombin III Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.7.5 Kedrion Recent Developments
• 11.8 Octapharma
  • 11.8.1 Octapharma Corporation Information
  • 11.8.2 Octapharma Overview
  • 11.8.3 Octapharma Human Antithrombin III Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.8.4 Octapharma Human Antithrombin III Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.8.5 Octapharma Recent Developments

12 Industry Chain and Sales Channels Analysis

• 12.1 Human Antithrombin III Industry Chain Analysis
• 12.2 Human Antithrombin III Key Raw Materials
  • 12.2.1 Key Raw Materials
  • 12.2.2 Raw Materials Key Suppliers
• 12.3 Human Antithrombin III Production Mode & Process
• 12.4 Human Antithrombin III Sales and Marketing
  • 12.4.1 Human Antithrombin III Sales Channels
  • 12.4.2 Human Antithrombin III Distributors
• 12.5 Human Antithrombin III Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis

• 13.1 Human Antithrombin III Industry Trends
• 13.2 Human Antithrombin III Market Drivers
• 13.3 Human Antithrombin III Market Challenges
• 13.4 Human Antithrombin III Market Restraints

14 Key Findings in The Global Human Antithrombin III Study

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Author Details
• 15.3 Disclaimer

List of Tables

• Table 1. Global Human Antithrombin III Market Size Growth Rate by Form, 2017 VS 2021 VS 2028 (US$ Million)
• Table 2. Major Manufacturers of Lyophilized Form
• Table 3. Major Manufacturers of Liquid Form
• Table 4. Global Human Antithrombin III Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
• Table 5. Global Human Antithrombin III Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
• Table 6. Global Human Antithrombin III Sales by Region (2017-2022) & (K Bottles)
• Table 7. Global Human Antithrombin III Sales Market Share by Region (2017-2022)
• Table 8. Global Human Antithrombin III Sales by Region (2023-2028) & (K Bottles)
• Table 9. Global Human Antithrombin III Sales Market Share by Region (2023-2028)
• Table 10. Global Human Antithrombin III Revenue by Region (2017-2022) & (US$ Million)
• Table 11. Global Human Antithrombin III Revenue Market Share by Region (2017-2022)
• Table 12. Global Human Antithrombin III Revenue by Region (2023-2028) & (US$ Million)
• Table 13. Global Human Antithrombin III Revenue Market Share by Region (2023-2028)
• Table 14. Global Human Antithrombin III Sales by Manufacturers (2017-2022) & (K Bottles)
• Table 15. Global Human Antithrombin III Sales Share by Manufacturers (2017-2022)
• Table 16. Global Human Antithrombin III Revenue by Manufacturers (2017-2022) & (US$ Million)
• Table 17. Global Human Antithrombin III Revenue Share by Manufacturers (2017-2022)
• Table 18. Human Antithrombin III Price by Manufacturers (2017-2022) &(US$/Bottle)
• Table 19. Global Human Antithrombin III Manufacturers Market Concentration Ratio (CR5 and HHI)
• Table 20. Global Human Antithrombin III by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Antithrombin III as of 2021)
• Table 21. Human Antithrombin III Manufacturing Base Distribution and Headquarters
• Table 22. Manufacturers Human Antithrombin III Product Offered
• Table 23. Date of Manufacturers Enter into Human Antithrombin III Market
• Table 24. Mergers & Acquisitions, Expansion Plans
• Table 25. Global Human Antithrombin III Sales by Form (2017-2022) & (K Bottles)
• Table 26. Global Human Antithrombin III Sales by Form (2023-2028) & (K Bottles)
• Table 27. Global Human Antithrombin III Sales Share by Form (2017-2022)
• Table 28. Global Human Antithrombin III Sales Share by Form (2023-2028)
• Table 29. Global Human Antithrombin III Revenue by Form (2017-2022) & (US$ Million)
• Table 30. Global Human Antithrombin III Revenue by Form (2023-2028) & (US$ Million)
• Table 31. Global Human Antithrombin III Revenue Share by Form (2017-2022)
• Table 32. Global Human Antithrombin III Revenue Share by Form (2023-2028)
• Table 33. Human Antithrombin III Price by Form (2017-2022) & (US$/Bottle)
• Table 34. Global Human Antithrombin III Price Forecast by Form (2023-2028) & (US$/Bottle)
• Table 35. Global Human Antithrombin III Sales by Application (2017-2022) & (K Bottles)
• Table 36. Global Human Antithrombin III Sales by Application (2023-2028) & (K Bottles)
• Table 37. Global Human Antithrombin III Sales Share by Application (2017-2022)
• Table 38. Global Human Antithrombin III Sales Share by Application (2023-2028)
• Table 39. Global Human Antithrombin III Revenue by Application (2017-2022) & (US$ Million)
• Table 40. Global Human Antithrombin III Revenue by Application (2023-2028) & (US$ Million)
• Table 41. Global Human Antithrombin III Revenue Share by Application (2017-2022)
• Table 42. Global Human Antithrombin III Revenue Share by Application (2023-2028)
• Table 43. Human Antithrombin III Price by Application (2017-2022) & (US$/Bottle)
• Table 44. Global Human Antithrombin III Price Forecast by Application (2023-2028) & (US$/Bottle)
• Table 45. North America Human Antithrombin III Sales by Form (2017-2022) & (K Bottles)
• Table 46. North America Human Antithrombin III Sales by Form (2023-2028) & (K Bottles)
• Table 47. North America Human Antithrombin III Revenue by Form (2017-2022) & (US$ Million)
• Table 48. North America Human Antithrombin III Revenue by Form (2023-2028) & (US$ Million)
• Table 49. North America Human Antithrombin III Sales by Application (2017-2022) & (K Bottles)
• Table 50. North America Human Antithrombin III Sales by Application (2023-2028) & (K Bottles)
• Table 51. North America Human Antithrombin III Revenue by Application (2017-2022) & (US$ Million)
• Table 52. North America Human Antithrombin III Revenue by Application (2023-2028) & (US$ Million)
• Table 53. North America Human Antithrombin III Sales by Country (2017-2022) & (K Bottles)
• Table 54. North America Human Antithrombin III Sales by Country (2023-2028) & (K Bottles)
• Table 55. North America Human Antithrombin III Revenue by Country (2017-2022) & (US$ Million)
• Table 56. North America Human Antithrombin III Revenue by Country (2023-2028) & (US$ Million)
• Table 57. Europe Human Antithrombin III Sales by Form (2017-2022) & (K Bottles)
• Table 58. Europe Human Antithrombin III Sales by Form (2023-2028) & (K Bottles)
• Table 59. Europe Human Antithrombin III Revenue by Form (2017-2022) & (US$ Million)
• Table 60. Europe Human Antithrombin III Revenue by Form (2023-2028) & (US$ Million)
• Table 61. Europe Human Antithrombin III Sales by Application (2017-2022) & (K Bottles)
• Table 62. Europe Human Antithrombin III Sales by Application (2023-2028) & (K Bottles)
• Table 63. Europe Human Antithrombin III Revenue by Application (2017-2022) & (US$ Million)
• Table 64. Europe Human Antithrombin III Revenue by Application (2023-2028) & (US$ Million)
• Table 65. Europe Human Antithrombin III Sales by Country (2017-2022) & (K Bottles)
• Table 66. Europe Human Antithrombin III Sales by Country (2023-2028) & (K Bottles)
• Table 67. Europe Human Antithrombin III Revenue by Country (2017-2022) & (US$ Million)
• Table 68. Europe Human Antithrombin III Revenue by Country (2023-2028) & (US$ Million)
• Table 69. Asia Pacific Human Antithrombin III Sales by Form (2017-2022) & (K Bottles)
• Table 70. Asia Pacific Human Antithrombin III Sales by Form (2023-2028) & (K Bottles)
• Table 71. Asia Pacific Human Antithrombin III Revenue by Form (2017-2022) & (US$ Million)
• Table 72. Asia Pacific Human Antithrombin III Revenue by Form (2023-2028) & (US$ Million)
• Table 73. Asia Pacific Human Antithrombin III Sales by Application (2017-2022) & (K Bottles)
• Table 74. Asia Pacific Human Antithrombin III Sales by Application (2023-2028) & (K Bottles)
• Table 75. Asia Pacific Human Antithrombin III Revenue by Application (2017-2022) & (US$ Million)
• Table 76. Asia Pacific Human Antithrombin III Revenue by Application (2023-2028) & (US$ Million)
• Table 77. Asia Pacific Human Antithrombin III Sales by Region (2017-2022) & (K Bottles)
• Table 78. Asia Pacific Human Antithrombin III Sales by Region (2023-2028) & (K Bottles)
• Table 79. Asia Pacific Human Antithrombin III Revenue by Region (2017-2022) & (US$ Million)
• Table 80. Asia Pacific Human Antithrombin III Revenue by Region (2023-2028) & (US$ Million)
• Table 81. Latin America Human Antithrombin III Sales by Form (2017-2022) & (K Bottles)
• Table 82. Latin America Human Antithrombin III Sales by Form (2023-2028) & (K Bottles)
• Table 83. Latin America Human Antithrombin III Revenue by Form (2017-2022) & (US$ Million)
• Table 84. Latin America Human Antithrombin III Revenue by Form (2023-2028) & (US$ Million)
• Table 85. Latin America Human Antithrombin III Sales by Application (2017-2022) & (K Bottles)
• Table 86. Latin America Human Antithrombin III Sales by Application (2023-2028) & (K Bottles)
• Table 87. Latin America Human Antithrombin III Revenue by Application (2017-2022) & (US$ Million)
• Table 88. Latin America Human Antithrombin III Revenue by Application (2023-2028) & (US$ Million)
• Table 89. Latin America Human Antithrombin III Sales by Country (2017-2022) & (K Bottles)
• Table 90. Latin America Human Antithrombin III Sales by Country (2023-2028) & (K Bottles)
• Table 91. Latin America Human Antithrombin III Revenue by Country (2017-2022) & (US$ Million)
• Table 92. Latin America Human Antithrombin III Revenue by Country (2023-2028) & (US$ Million)
• Table 93. Middle East and Africa Human Antithrombin III Sales by Form (2017-2022) & (K Bottles)
• Table 94. Middle East and Africa Human Antithrombin III Sales by Form (2023-2028) & (K Bottles)
• Table 95. Middle East and Africa Human Antithrombin III Revenue by Form (2017-2022) & (US$ Million)
• Table 96. Middle East and Africa Human Antithrombin III Revenue by Form (2023-2028) & (US$ Million)
• Table 97. Middle East and Africa Human Antithrombin III Sales by Application (2017-2022) & (K Bottles)
• Table 98. Middle East and Africa Human Antithrombin III Sales by Application (2023-2028) & (K Bottles)
• Table 99. Middle East and Africa Human Antithrombin III Revenue by Application (2017-2022) & (US$ Million)
• Table 100. Middle East and Africa Human Antithrombin III Revenue by Application (2023-2028) & (US$ Million)
• Table 101. Middle East and Africa Human Antithrombin III Sales by Country (2017-2022) & (K Bottles)
• Table 102. Middle East and Africa Human Antithrombin III Sales by Country (2023-2028) & (K Bottles)
• Table 103. Middle East and Africa Human Antithrombin III Revenue by Country (2017-2022) & (US$ Million)
• Table 104. Middle East and Africa Human Antithrombin III Revenue by Country (2023-2028) & (US$ Million)
• Table 105. Grifols Corporation Information
• Table 106. Grifols Description and Major Businesses
• Table 107. Grifols Human Antithrombin III Sales (K Bottles), Revenue (US$ Million), Price (US$/Bottle) and Gross Margin (2017-2022)
• Table 108. Grifols Human Antithrombin III Product Model Numbers, Pictures, Descriptions and Specifications
• Table 109. Grifols Recent Developments
• Table 110. Lee BioSolutions Corporation Information
• Table 111. Lee BioSolutions Description and Major Businesses
• Table 112. Lee BioSolutions Human Antithrombin III Sales (K Bottles), Revenue (US$ Million), Price (US$/Bottle) and Gross Margin (2017-2022)
• Table 113. Lee BioSolutions Human Antithrombin III Product Model Numbers, Pictures, Descriptions and Specifications
• Table 114. Lee BioSolutions Recent Developments
• Table 115. ATryn Corporation Information
• Table 116. ATryn Description and Major Businesses
• Table 117. ATryn Human Antithrombin III Sales (K Bottles), Revenue (US$ Million), Price (US$/Bottle) and Gross Margin (2017-2022)
• Table 118. ATryn Human Antithrombin III Product Model Numbers, Pictures, Descriptions and Specifications
• Table 119. ATryn Recent Developments
• Table 120. LFB Corporation Information
• Table 121. LFB Description and Major Businesses
• Table 122. LFB Human Antithrombin III Sales (K Bottles), Revenue (US$ Million), Price (US$/Bottle) and Gross Margin (2017-2022)
• Table 123. LFB Human Antithrombin III Product Model Numbers, Pictures, Descriptions and Specifications
• Table 124. LFB Recent Developments
• Table 125. Shire Corporation Information
• Table 126. Shire Description and Major Businesses
• Table 127. Shire Human Antithrombin III Sales (K Bottles), Revenue (US$ Million), Price (US$/Bottle) and Gross Margin (2017-2022)
• Table 128. Shire Human Antithrombin III Product Model Numbers, Pictures, Descriptions and Specifications
• Table 129. Shire Recent Developments
• Table 130. CSL Limited Corporation Information
• Table 131. CSL Limited Description and Major Businesses
• Table 132. CSL Limited Human Antithrombin III Sales (K Bottles), Revenue (US$ Million), Price (US$/Bottle) and Gross Margin (2017-2022)
• Table 133. CSL Limited Human Antithrombin III Product Model Numbers, Pictures, Descriptions and Specifications
• Table 134. CSL Limited Recent Developments
• Table 135. Kedrion Corporation Information
• Table 136. Kedrion Description and Major Businesses
• Table 137. Kedrion Human Antithrombin III Sales (K Bottles), Revenue (US$ Million), Price (US$/Bottle) and Gross Margin (2017-2022)
• Table 138. Kedrion Human Antithrombin III Product Model Numbers, Pictures, Descriptions and Specifications
• Table 139. Kedrion Recent Developments
• Table 140. Octapharma Corporation Information
• Table 141. Octapharma Description and Major Businesses
• Table 142. Octapharma Human Antithrombin III Sales (K Bottles), Revenue (US$ Million), Price (US$/Bottle) and Gross Margin (2017-2022)
• Table 143. Octapharma Human Antithrombin III Product Model Numbers, Pictures, Descriptions and Specifications
• Table 144. Octapharma Recent Developments
• Table 145. Key Raw Materials Lists
• Table 146. Raw Materials Key Suppliers Lists
• Table 147. Human Antithrombin III Distributors List
• Table 148. Human Antithrombin III Customers List
• Table 149. Human Antithrombin III Market Trends
• Table 150. Human Antithrombin III Market Drivers
• Table 151. Human Antithrombin III Market Challenges
• Table 152. Human Antithrombin III Market Restraints
• Table 153. Research Programs/Design for This Report
• Table 154. Key Data Information from Secondary Sources
• Table 155. Key Data Information from Primary Sources

List of Figures

• Figure 1. Human Antithrombin III Product Picture
• Figure 3. Global Human Antithrombin III Market Share by Form in 2021 & 2028
• Figure 3. Lyophilized Form Product Picture
• Figure 4. Liquid Form Product Picture
• Figure 5. Global Human Antithrombin III Market Share by Application in 2021 & 2028
• Figure 6. Hmophilia
• Figure 7. Aplastic Anemia
• Figure 8. Heart Valve Disease
• Figure 9. Other
• Figure 10. Human Antithrombin III Report Years Considered
• Figure 11. Global Human Antithrombin III Sales 2017-2028 (K Bottles)
• Figure 12. Global Human Antithrombin III Revenue, (US$ Million), 2017 VS 2021 VS 2028
• Figure 13. Global Human Antithrombin III Revenue 2017-2028 (US$ Million)
• Figure 14. Global Human Antithrombin III Revenue Market Share by Region in Percentage: 2021 Versus 2028
• Figure 15. Global Human Antithrombin III Sales Market Share by Region (2017-2022)
• Figure 16. Global Human Antithrombin III Sales Market Share by Region (2023-2028)
• Figure 17. North America Human Antithrombin III Sales YoY (2017-2028) & (K Bottles)
• Figure 18. North America Human Antithrombin III Revenue YoY (2017-2028) & (US$ Million)
• Figure 19. Europe Human Antithrombin III Sales YoY (2017-2028) & (K Bottles)
• Figure 20. Europe Human Antithrombin III Revenue YoY (2017-2028) & (US$ Million)
• Figure 21. Asia-Pacific Human Antithrombin III Sales YoY (2017-2028) & (K Bottles)
• Figure 22. Asia-Pacific Human Antithrombin III Revenue YoY (2017-2028) & (US$ Million)
• Figure 23. Latin America Human Antithrombin III Sales YoY (2017-2028) & (K Bottles)
• Figure 24. Latin America Human Antithrombin III Revenue YoY (2017-2028) & (US$ Million)
• Figure 25. Middle East & Africa Human Antithrombin III Sales YoY (2017-2028) & (K Bottles)
• Figure 26. Middle East & Africa Human Antithrombin III Revenue YoY (2017-2028) & (US$ Million)
• Figure 27. The Human Antithrombin III Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
• Figure 28. The Top 5 and 10 Largest Manufacturers of Human Antithrombin III in the World: Market Share by Human Antithrombin III Revenue in 2021
• Figure 29. Global Human Antithrombin III Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
• Figure 30. Global Human Antithrombin III Sales Market Share by Form (2017-2028)
• Figure 31. Global Human Antithrombin III Revenue Market Share by Form (2017-2028)
• Figure 32. Global Human Antithrombin III Sales Market Share by Application (2017-2028)
• Figure 33. Global Human Antithrombin III Revenue Market Share by Application (2017-2028)
• Figure 34. North America Human Antithrombin III Sales Market Share by Form (2017-2028)
• Figure 35. North America Human Antithrombin III Revenue Market Share by Form (2017-2028)
• Figure 36. North America Human Antithrombin III Sales Market Share by Application (2017-2028)
• Figure 37. North America Human Antithrombin III Revenue Market Share by Application (2017-2028)
• Figure 38. North America Human Antithrombin III Sales Share by Country (2017-2028)
• Figure 39. North America Human Antithrombin III Revenue Share by Country (2017-2028)
• Figure 40. United States Human Antithrombin III Revenue (2017-2028) & (US$ Million)
• Figure 41. Canada Human Antithrombin III Revenue (2017-2028) & (US$ Million)
• Figure 42. Europe Human Antithrombin III Sales Market Share by Form (2017-2028)
• Figure 43. Europe Human Antithrombin III Revenue Market Share by Form (2017-2028)
• Figure 44. Europe Human Antithrombin III Sales Market Share by Application (2017-2028)
• Figure 45. Europe Human Antithrombin III Revenue Market Share by Application (2017-2028)
• Figure 46. Europe Human Antithrombin III Sales Share by Country (2017-2028)
• Figure 47. Europe Human Antithrombin III Revenue Share by Country (2017-2028)
• Figure 48. Germany Human Antithrombin III Revenue (2017-2028) & (US$ Million)
• Figure 49. France Human Antithrombin III Revenue (2017-2028) & (US$ Million)
• Figure 50. U.K. Human Antithrombin III Revenue (2017-2028) & (US$ Million)
• Figure 51. Italy Human Antithrombin III Revenue (2017-2028) & (US$ Million)
• Figure 52. Russia Human Antithrombin III Revenue (2017-2028) & (US$ Million)
• Figure 53. Asia Pacific Human Antithrombin III Sales Market Share by Form (2017-2028)
• Figure 54. Asia Pacific Human Antithrombin III Revenue Market Share by Form (2017-2028)
• Figure 55. Asia Pacific Human Antithrombin III Sales Market Share by Application (2017-2028)
• Figure 56. Asia Pacific Human Antithrombin III Revenue Market Share by Application (2017-2028)
• Figure 57. Asia Pacific Human Antithrombin III Sales Share by Region (2017-2028)
• Figure 58. Asia Pacific Human Antithrombin III Revenue Share by Region (2017-2028)
• Figure 59. China Human Antithrombin III Revenue (2017-2028) & (US$ Million)
• Figure 60. Japan Human Antithrombin III Revenue (2017-2028) & (US$ Million)
• Figure 61. South Korea Human Antithrombin III Revenue (2017-2028) & (US$ Million)
• Figure 62. India Human Antithrombin III Revenue (2017-2028) & (US$ Million)
• Figure 63. Australia Human Antithrombin III Revenue (2017-2028) & (US$ Million)
• Figure 64. China Taiwan Human Antithrombin III Revenue (2017-2028) & (US$ Million)
• Figure 65. Indonesia Human Antithrombin III Revenue (2017-2028) & (US$ Million)
• Figure 66. Thailand Human Antithrombin III Revenue (2017-2028) & (US$ Million)
• Figure 67. Malaysia Human Antithrombin III Revenue (2017-2028) & (US$ Million)
• Figure 68. Latin America Human Antithrombin III Sales Market Share by Form (2017-2028)
• Figure 69. Latin America Human Antithrombin III Revenue Market Share by Form (2017-2028)
• Figure 70. Latin America Human Antithrombin III Sales Market Share by Application (2017-2028)
• Figure 71. Latin America Human Antithrombin III Revenue Market Share by Application (2017-2028)
• Figure 72. Latin America Human Antithrombin III Sales Share by Country (2017-2028)
• Figure 73. Latin America Human Antithrombin III Revenue Share by Country (2017-2028)
• Figure 74. Mexico Human Antithrombin III Revenue (2017-2028) & (US$ Million)
• Figure 75. Brazil Human Antithrombin III Revenue (2017-2028) & (US$ Million)
• Figure 76. Argentina Human Antithrombin III Revenue (2017-2028) & (US$ Million)
• Figure 77. Middle East and Africa Human Antithrombin III Sales Market Share by Form (2017-2028)
• Figure 78. Middle East and Africa Human Antithrombin III Revenue Market Share by Form (2017-2028)
• Figure 79. Middle East and Africa Human Antithrombin III Sales Market Share by Application (2017-2028)
• Figure 80. Middle East and Africa Human Antithrombin III Revenue Market Share by Application (2017-2028)
• Figure 81. Middle East and Africa Human Antithrombin III Sales Share by Country (2017-2028)
• Figure 82. Middle East and Africa Human Antithrombin III Revenue Share by Country (2017-2028)
• Figure 83. Turkey Human Antithrombin III Revenue (2017-2028) & (US$ Million)
• Figure 84. Saudi Arabia Human Antithrombin III Revenue (2017-2028) & (US$ Million)
• Figure 85. UAE Human Antithrombin III Revenue (2017-2028) & (US$ Million)
• Figure 86. Human Antithrombin III Value Chain
• Figure 87. Human Antithrombin III Production Process
• Figure 88. Channels of Distribution
• Figure 89. Distributors Profiles
• Figure 90. Bottom-up and Top-down Approaches for This Report
• Figure 91. Data Triangulation
• Figure 92. Key Executives Interviewed